Clinical Trial Update: A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study of EBV-specific T cell therapy for nasopharyngeal carcinoma, investigating safety and early signs of effi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• EBV-specific T cell therapy (EBV-specific T cells)

Snippet

Sponsor: The Second Hospital of Nanjing Medical University | Conditions: Nasopharyngeal Neoplasms | Phase 1, Phase 2 | Status: UNKNOWN